💡 Real-world imaging data (RWiD) is becoming a game-changer in medical device innovation
For decades, medical devices were validated primarily through controlled clinical trials. But today, regulators, payers, and innovators are turning to real-world imaging data to prove safety, performance, and patient outcomes in everyday clinical practice.
In our latest blog, we explore:
🔹 Why device companies are shifting to RWiD for development, validation, and regulatory readiness
🔹 How RWiD reduces bias, enhances equity, and accelerates R&D timelines
🔹 Real-world applications—risk stratification, regulatory submissions, and 360° device performance insights
🔹 How Segmed provides access to 100M+ regulatory-grade imaging datasets to power safer, faster, and more effective MedTech innovation
👉 Read the full article here: https://www.segmed.ai/resources/blog/real-world-imaging-data-in-medtech-innovation
At Segmed, we’re helping MedTech companies transform innovation with diverse, high-quality imaging data—supporting earlier detection, stronger regulatory submissions, and better outcomes for patients worldwide.
